Press Releases – Page 16

21/09/2020: Theradiag publishes 2020 H1 results

Post author:Ingrid Chemin
Post published:21 September 2020
Post category:Press Releases

· Robust resilience in revenues at €4.9 million driven by Theranostic up +16.5% · Continued investment in R&D to drive future growth · North America business accelerates · Sound cash position at €1.7 million · Launch…

16/09/2020: Theradiag announces the launch of a new range of assays for automated Therapeutic Drug Monitoring of Biologics for use on IDS-iSYS

Post author:Ingrid Chemin
Post published:16 September 2020
Post category:Press Releases

Croissy-Beaubourg, September, 16, 2020, 8:00 am CEST – THERADIAG (ISIN: FR0004197747, Ticker: ALTER, eligible for the French PEA-PME personal equity plan), a company specializing in in vitro diagnostics and theranostics, is pleased to announce the…

07/09/2020 : THERADIAG publiera ses résultats semestriels 2020 le 21 septembre 2020 après clôture des marchés et tiendra une conférence téléphonique le 22 septembre

Post author:Ingrid Chemin
Post published:7 September 2020
Post category:Press Releases

Croissy-Beaubourg, le 7 septembre, 17h45 CEST – THERADIAG (ISIN : FR0004197747, Mnémonique : ALTER), société spécialisée dans le diagnostic in vitro des maladies auto-immunes et le Théranostic publiera ses résultats semestriels consolidés clos au 30 juin…